Lilly Phase 2 Data Show Eloratzp Weight Loss of Up to 54.1 Pounds
Phase 2 data showed average weight loss of up to 54.1 pounds (23.3%) at 48 weeks in adults with obesity and type 2 diabetes.
Story updates
05:01:07 PM UTC
SquawkNews
Phase 2 results showed EloraTZP, an investigational combination of eloralintide and tirzepatide, del